The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys-Reference-Cited by-同舟云学术

The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys

Published:2001-03 Issue:1 Volume:415 Page:79-84
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

van Heek Margaret,Compton Douglas S,Davis Harry R

Publisher

Elsevier BV

Subject

Pharmacology

Reference21 articles.

1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

2. The clinical development of a novel cholesterol absorption inhibitor;Bergman,1995

3. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum;Havel;J. Clin. Invest.,1955

4. Postprandial lipoprotein metabolism and atherosclerosis;Karpe;J. Intern. Med.,1999

5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;N. Engl. J. Med.,1998

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of micelle characteristics on cholesterol absorption and ezetimibe inhibition: Insights from Niemann-Pick C1-like 1 binding and molecular structure;Journal of Liposome Research;2023-10-31

2. Nanoformulation of Seaweed Eisenia bicyclis in Albumin Nanoparticles Targeting Cardiovascular Diseases: In Vitro and In Vivo Evaluation;Marine Drugs;2022-09-27

3. Atherosclerosis: Cholesterol Management;Burger's Medicinal Chemistry and Drug Discovery;2021-04-22

4. Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia;American Journal of Cardiovascular Drugs;2020-07-10

5. Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters;Lipids in Health and Disease;2020-02-08